147 related articles for article (PubMed ID: 15998564)
1. Effectiveness of oral desmopressin therapy in posterior urethral valve patients with polyuria and detection of factors affecting the therapy.
Naghizadeh S; Kefi A; Dogan HS; Burgu B; Akdogan B; Tekgul S
Eur Urol; 2005 Nov; 48(5):819-25. PubMed ID: 15998564
[TBL] [Abstract][Full Text] [Related]
2. Antidiuretic hormone in elderly male patients with severe nocturia: a circadian study.
Moon DG; Jin MH; Lee JG; Kim JJ; Kim MG; Cha DR
BJU Int; 2004 Sep; 94(4):571-5. PubMed ID: 15329115
[TBL] [Abstract][Full Text] [Related]
3. Peroral treatment of diabetes insipidus with a polypeptide hormone analog, desmopressin.
Hammer M; Vilhardt H
J Pharmacol Exp Ther; 1985 Sep; 234(3):754-60. PubMed ID: 4032289
[TBL] [Abstract][Full Text] [Related]
4. [The use of desmopressin as an alternative in the treatment of nycturia in patients with benign prostatic hyperplasia (BPH)].
Granados Loarca EA; Garat Barredo JM; Villavicencio Mavrich H
Actas Urol Esp; 1999 Jan; 23(1):56-9. PubMed ID: 10089634
[TBL] [Abstract][Full Text] [Related]
5. Initial surgical treatment as a determinant of bladder dysfunction in posterior urethral valves.
Puri A; Grover VP; Agarwala S; Mitra DK; Bhatnagar V
Pediatr Surg Int; 2002 Sep; 18(5-6):438-43. PubMed ID: 12415375
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of intranasal desmopressin for men with benign prostatic hyperplasia and nocturia: preliminary results.
Chancellor MB; Atan A; Rivas DA; Watanabe T; Tai HL; Kumon H
Tech Urol; 1999 Dec; 5(4):191-4. PubMed ID: 10591256
[TBL] [Abstract][Full Text] [Related]
7. [Oxybutinin-desmopressin association in the treatment of primary nocturnal enuresis with diurnal urination disorders].
De Grazia E; Cimador M
Minerva Pediatr; 1999 May; 51(5):149-52. PubMed ID: 10479880
[TBL] [Abstract][Full Text] [Related]
8. [Long-term treatment of central diabetes insipidus with oral DDAVP].
Carraro A; Fano M; Cuttica M; Bernareggi V; Giusti M; Giordano G
Minerva Endocrinol; 1992; 17(4):189-93. PubMed ID: 1308923
[TBL] [Abstract][Full Text] [Related]
9. The Canadian Enuresis Study and Evaluation--short- and long-term safety and efficacy of an oral desmopressin preparation.
Wolfish NM; Barkin J; Gorodzinsky F; Schwarz R
Scand J Urol Nephrol; 2003; 37(1):22-7. PubMed ID: 12745738
[TBL] [Abstract][Full Text] [Related]
10. Early prognostic value of serum creatinine levels in children with posterior urethral valves.
Denes ED; Barthold JS; González R
J Urol; 1997 Apr; 157(4):1441-3. PubMed ID: 9120976
[TBL] [Abstract][Full Text] [Related]
11. [In which patients is the oxybutynin-desmopressin combination therapy indicated?].
Martín-Crespo R; Luque R
Cir Pediatr; 2003 Oct; 16(4):181-5. PubMed ID: 14677356
[TBL] [Abstract][Full Text] [Related]
12. Urodynamic findings of posterior urethral valve patients.
Emir H; Eroğlu E; Tekant G; Büyükünal C; Danişmend N; Söylet Y
Eur J Pediatr Surg; 2002 Feb; 12(1):38-41. PubMed ID: 11967758
[TBL] [Abstract][Full Text] [Related]
13. Nocturia: a new perspective on an old symptom.
Lundgren R
Scand J Urol Nephrol; 2004; 38(2):112-6. PubMed ID: 15204390
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson's disease.
Suchowersky O; Furtado S; Rohs G
Mov Disord; 1995 May; 10(3):337-40. PubMed ID: 7651453
[TBL] [Abstract][Full Text] [Related]
15. Desmopressin in the treatment of nocturnal polyuria in the male.
Reynard J
BJU Int; 2000 Feb; 85(3):380-1. PubMed ID: 10744454
[No Abstract] [Full Text] [Related]
16. The effect of intranasal desmopressin on nocturnal waking in urination in multiple system atrophy patients with nocturnal polyuria.
Sakakibara R; Matsuda S; Uchiyama T; Yoshiyama M; Yamanishi T; Hattori T
Clin Auton Res; 2003 Apr; 13(2):106-8. PubMed ID: 12720096
[TBL] [Abstract][Full Text] [Related]
17. Oral desmopressin for nocturnal polyuria in elderly subjects: a double-blind, placebo-controlled randomized exploratory study.
Asplund R; Sundberg B; Bengtsson P
BJU Int; 1999 Apr; 83(6):591-5. PubMed ID: 10233563
[TBL] [Abstract][Full Text] [Related]
18. Primary bladder neck dysfunction in children and adolescents II: results of treatment with alpha-adrenergic antagonists.
Donohoe JM; Combs AJ; Glassberg KI
J Urol; 2005 Jan; 173(1):212-6. PubMed ID: 15592078
[TBL] [Abstract][Full Text] [Related]
19. Four-hour voiding observation in young boys with posterior urethral valves.
Holmdahl G; Hanson E; Hanson M; Hellström AL; Sillén U; Sölsnes E
J Urol; 1998 Oct; 160(4):1477-81. PubMed ID: 9751398
[TBL] [Abstract][Full Text] [Related]
20. The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children.
Seear MD; Wadsworth LD; Rogers PC; Sheps S; Ashmore PG
J Thorac Cardiovasc Surg; 1989 Aug; 98(2):217-9. PubMed ID: 2666759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
